Author: Sarkar, Malay; Madabhavi, Irappa V.; Quy, Pham Nguyen; Govindagoudar, Manjunath B.
Title: COVIDâ€19 and coagulopathy Cord-id: 3illyta0 Document date: 2021_8_30
ID: 3illyta0
Snippet: The SARSâ€CoVâ€2 is a new coronavirus responsible for the COVIDâ€19 disease and has caused the pandemic worldwide. A large number of cases have overwhelmed the healthcare system worldwide. The COVIDâ€19 infection has been associated with a heightened risk of thromboembolic complications. Various mechanisms are leading to the high thrombotic risk in COVIDâ€19 patients such as inflammation, endotheliitis, hyperviscosity, and hypercoagulability. We searched PubMed, EMBASE, and CINAHL from Janu
Document: The SARSâ€CoVâ€2 is a new coronavirus responsible for the COVIDâ€19 disease and has caused the pandemic worldwide. A large number of cases have overwhelmed the healthcare system worldwide. The COVIDâ€19 infection has been associated with a heightened risk of thromboembolic complications. Various mechanisms are leading to the high thrombotic risk in COVIDâ€19 patients such as inflammation, endotheliitis, hyperviscosity, and hypercoagulability. We searched PubMed, EMBASE, and CINAHL from January 2020 to December 2020. We used the following search terms: COVIDâ€19, coagulopathy, and thrombosis. We reviewed the epidemiology, clinical features, mechanisms, and treatment of COVIDâ€19â€associated coagulopathy.
Search related documents:
Co phrase search for related documents- activate complement and acute illness: 1
Co phrase search for related documents, hyperlinks ordered by date